132 South 10th Street
Suite 766D, Main Building
Philadelphia, PA 19107
(215) 955-6385
(215) 955-6754 fax
Suite 766D, Main Building
Philadelphia, PA 19107
(215) 955-6385
(215) 955-6754 fax
Most Recent Peer-reviewed Publications
- Transhepatic therapies for metastatic uveal melanoma
- Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma
- Role of MR imaging of uterine leiomyomas before and after embolization
- Safety of uterine artery embolization in patients with preexisting hydrosalpinx
- Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: Are contact restrictions necessary?
- Segmental arterial mediolysis: Report of 2 cases and review of the literature
- Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
- Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: A pilot study
- Side-branch embolization before 90Y radioembolization: Rate of recanalization and new collateral development
- The use of a covered stent in carotid blowout syndrome
- Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: A single-institution experience
- Management of hypersplenism by partial splenic embolization with ethylene vinyl alcohol copolymer
- One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin
- Spectrum of imaging findings on MRI and CT after uterine artery embolization
- May-Thurner syndrome: Case report and review of the literature involving modern endovascular therapy
- Chemoembolization of hepatic malignancy
- High-dose immunoembolization: Survival benefit in patients with he 058E patic metastases from uveal melanoma
- Uterine artery embolization for treatment of symptomatic fibroids
- Chemoembolization of hepatic malignancy
- Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor